Other trials demonstrated ACE inhibitors (ACEIs) and ACE receptor blockers (ARBs) restore normal lung function in mice, indicating utility for COVID-19-induced ARDS (19, 45, 46). Here, ACE is linked to acute respiratory distress syndrome.